FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150168239> ?p ?o ?g. }

• W2150168239 endingPage "619" @default.
• W2150168239 startingPage "612" @default.
• W2150168239 abstract "The combination of stent insertion and single high-dose brachytherapy is a feasible and safe palliative treatment regimen in patients with unresectable oesophageal cancer. We aimed to further assess the efficacy of this treatment strategy compared to a conventional covered stent in patients with dysphagia caused by unresectable oesophageal cancer.In this multicentre, single-blind, randomised, phase 3 trial, we enrolled patients with unresectable oesophageal cancer from 16 hospitals in China. We included adult patients (aged ≥ 20 years) with progressive dysphagia, unresectable tumours due to extensive lesions, metastases, or poor medical condition, and with clear consciousness, cooperation, and an Eastern Cooperative Oncology Group (ECOG) performance status score of 0-3. Eligible patients were randomly assigned (in 1:1 ratio, no stratification) to receive either a stent loaded with (125)iodine radioactive seeds (irradiation group) or a conventional oesophageal stent (control group). The primary endpoint was overall survival. Survival analyses were done in a modified intention-to-treat group. This study is registered with ClinicalTrials.gov, number NCT01054274.Between Nov 1, 2009, and Oct 31, 2012, 160 patients were randomly assigned to receive treatment with either an irradiation stent (n=80) or a conventional stent (n=80). During a median follow-up of 138 days (IQR 72-207), 148 stents (73 in the irradiation group and 75 in the control group) were successfully placed into the diseased oesophagus in 148 participants. Median overall survival was 177 days (95% CI 153-201) in the irradiation group versus 147 days (124-170) in the control group (p=0.0046). Major complications and side-effects of the treatment were severe chest pain (17 [23%] of 73 patients in the irradiation group vs 15 [20%] of 75 patents in the control group), fistula formation (six [8%] vs five [7%]), aspiration pneumonia (11 [15%] vs 14 [19%]), haemorrhage (five [7%] vs five [7%]), and recurrent dysphagia (21 [28%] vs 20 [27%]).In patients with unresectable oesophageal cancer, the insertion of an oesophageal stent loaded with (125)iodine seeds prolonged survival when compared with the insertion of a conventional covered self-expandable metallic stent." @default.
• W2150168239 created "2016-06-24" @default.
• W2150168239 creator A5005747106 @default.
• W2150168239 creator A5005900235 @default.
• W2150168239 creator A5011397075 @default.
• W2150168239 creator A5012463457 @default.
• W2150168239 creator A5026255829 @default.
• W2150168239 creator A5031639923 @default.
• W2150168239 creator A5032103159 @default.
• W2150168239 creator A5032533121 @default.
• W2150168239 creator A5037989560 @default.
• W2150168239 creator A5051691879 @default.
• W2150168239 creator A5052225808 @default.
• W2150168239 creator A5058020568 @default.
• W2150168239 creator A5067374801 @default.
• W2150168239 creator A5067814400 @default.
• W2150168239 creator A5075732221 @default.
• W2150168239 creator A5076887655 @default.
• W2150168239 creator A5078602309 @default.
• W2150168239 creator A5078795310 @default.
• W2150168239 creator A5080224324 @default.
• W2150168239 creator A5082320448 @default.
• W2150168239 creator A5086852891 @default.
• W2150168239 creator A5087016614 @default.
• W2150168239 creator A5090625691 @default.
• W2150168239 date "2014-05-01" @default.
• W2150168239 modified "2023-10-15" @default.
• W2150168239 title "Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial" @default.
• W2150168239 cites W141828790 @default.
• W2150168239 cites W1975500090 @default.
• W2150168239 cites W1999614232 @default.
• W2150168239 cites W2007899593 @default.
• W2150168239 cites W2022178046 @default.
• W2150168239 cites W2039324238 @default.
• W2150168239 cites W2040997890 @default.
• W2150168239 cites W2043127198 @default.
• W2150168239 cites W2044348284 @default.
• W2150168239 cites W2059497743 @default.
• W2150168239 cites W2069616419 @default.
• W2150168239 cites W2071177977 @default.
• W2150168239 cites W2079915228 @default.
• W2150168239 cites W2090121024 @default.
• W2150168239 cites W2105436322 @default.
• W2150168239 cites W2106787323 @default.
• W2150168239 cites W2120603938 @default.
• W2150168239 cites W2121241419 @default.
• W2150168239 cites W2129055079 @default.
• W2150168239 cites W2132307543 @default.
• W2150168239 cites W2135667552 @default.
• W2150168239 cites W2148152153 @default.
• W2150168239 cites W2151458978 @default.
• W2150168239 cites W2158526694 @default.
• W2150168239 cites W4211048478 @default.
• W2150168239 cites W4231760537 @default.
• W2150168239 cites W4252560545 @default.
• W2150168239 doi "https://doi.org/10.1016/s1470-2045(14)70131-7" @default.
• W2150168239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24742740" @default.
• W2150168239 hasPublicationYear "2014" @default.
• W2150168239 type Work @default.
• W2150168239 sameAs 2150168239 @default.
• W2150168239 citedByCount "120" @default.
• W2150168239 countsByYear W21501682392014 @default.
• W2150168239 countsByYear W21501682392015 @default.
• W2150168239 countsByYear W21501682392016 @default.
• W2150168239 countsByYear W21501682392017 @default.
• W2150168239 countsByYear W21501682392018 @default.
• W2150168239 countsByYear W21501682392019 @default.
• W2150168239 countsByYear W21501682392020 @default.
• W2150168239 countsByYear W21501682392021 @default.
• W2150168239 countsByYear W21501682392022 @default.
• W2150168239 countsByYear W21501682392023 @default.
• W2150168239 crossrefType "journal-article" @default.
• W2150168239 hasAuthorship W2150168239A5005747106 @default.
• W2150168239 hasAuthorship W2150168239A5005900235 @default.
• W2150168239 hasAuthorship W2150168239A5011397075 @default.
• W2150168239 hasAuthorship W2150168239A5012463457 @default.
• W2150168239 hasAuthorship W2150168239A5026255829 @default.
• W2150168239 hasAuthorship W2150168239A5031639923 @default.
• W2150168239 hasAuthorship W2150168239A5032103159 @default.
• W2150168239 hasAuthorship W2150168239A5032533121 @default.
• W2150168239 hasAuthorship W2150168239A5037989560 @default.
• W2150168239 hasAuthorship W2150168239A5051691879 @default.
• W2150168239 hasAuthorship W2150168239A5052225808 @default.
• W2150168239 hasAuthorship W2150168239A5058020568 @default.
• W2150168239 hasAuthorship W2150168239A5067374801 @default.
• W2150168239 hasAuthorship W2150168239A5067814400 @default.
• W2150168239 hasAuthorship W2150168239A5075732221 @default.
• W2150168239 hasAuthorship W2150168239A5076887655 @default.
• W2150168239 hasAuthorship W2150168239A5078602309 @default.
• W2150168239 hasAuthorship W2150168239A5078795310 @default.
• W2150168239 hasAuthorship W2150168239A5080224324 @default.
• W2150168239 hasAuthorship W2150168239A5082320448 @default.
• W2150168239 hasAuthorship W2150168239A5086852891 @default.
• W2150168239 hasAuthorship W2150168239A5087016614 @default.
• W2150168239 hasAuthorship W2150168239A5090625691 @default.
• W2150168239 hasConcept C121608353 @default.
• W2150168239 hasConcept C126322002 @default.
• W2150168239 hasConcept C141071460 @default.

• next